- Report
- March 2024
- 191 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- February 2024
- 280 Pages
Global
From €5234EUR$5,702USD£4,350GBP
- Report
- June 2023
- 140 Pages
Global
From €2374EUR$2,499USD£2,042GBP
- Report
- October 2023
- 181 Pages
Global
From €4655EUR$4,900USD£4,005GBP
- Report
- February 2024
- 114 Pages
Global
From €4513EUR$4,750USD£3,882GBP
- Report
- February 2024
- 111 Pages
Global
From €4513EUR$4,750USD£3,882GBP
- Report
- October 2023
- 180 Pages
Global
From €4655EUR$4,900USD£4,005GBP
- Report
- October 2023
- 145 Pages
Global
From €2993EUR$3,150USD£2,574GBP
- Report
- March 2024
- 198 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- May 2024
- 186 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- May 2024
- 196 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- March 2024
- 181 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- October 2023
- 150 Pages
Global
From €5653EUR$5,950USD£4,863GBP
- Report
- January 2024
- 200 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- February 2024
- 175 Pages
Global
From €3800EUR$4,000USD£3,269GBP
- Report
- February 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- February 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- January 2024
- 200 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- January 2024
- 200 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- January 2024
- 200 Pages
Global
From €4750EUR$5,000USD£4,086GBP
The Dermatologicals market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin diseases, including acne, psoriasis, eczema, and skin cancer. Dermatologicals are typically administered topically, although some may be taken orally. The market is highly competitive, with a wide range of products available from both generic and branded manufacturers.
The Dermatologicals market is driven by the increasing prevalence of skin diseases, as well as the development of new treatments and technologies. Additionally, the increasing demand for cosmetic treatments has also contributed to the growth of the market.
Some of the major companies in the Dermatologicals market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. Other notable players include Allergan, Galderma, and Sun Pharmaceuticals. Show Less Read more